TuHURA BIOSCIENCES, INC./NV Additional Paid in Capital
TuHURA BIOSCIENCES, INC./NV (HURA) had Additional Paid in Capital of $1.72 million as of 2015-06-30, per its 10-K filed 2015-11-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2015-11-16
- 2015-06-30: Additional Paid in Capital $1.72M.
- 2015-03-31: Additional Paid in Capital $2.88M.
- 2012-12-31: Additional Paid in Capital $45.56K.
- 2012-09-30: Additional Paid in Capital $45.56K.
| Period end | Additional Paid in Capital |
|---|---|
| 2015-06-30 | $1.72M 10-K · filed 2015-11-16 |
| 2015-03-31 | $2.88M 10-Q · filed 2015-05-15 |
| 2012-12-31 | $45.56K 10-Q · filed 2013-01-18 |
| 2012-09-30 | $45.56K 10-Q/A · filed 2012-12-20 |
| 2012-06-30 | $45.56K 10-Q · filed 2013-01-18 |
| 2012-03-31 | $45.56K 10-Q/A · filed 2012-06-05 |
| 2011-12-31 | $45.56K 10-Q · filed 2012-02-07 |
| 2011-09-30 | $43.55K 10-Q · filed 2011-11-10 |
| 2011-06-30 | $43.55K 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |